Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Other financing activities (2019 - 2024)

Cardiff Oncology (CRDF) has disclosed Other financing activities for 7 consecutive years, with $197000.0 as the latest value for Q2 2024.

  • Quarterly Other financing activities changed N/A to $197000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $997000.0 through Jun 2024, changed N/A year-over-year, with the annual reading at -$8000.0 for FY2020, 80.0% up from the prior year.
  • Other financing activities hit $197000.0 in Q2 2024 for Cardiff Oncology, down from $800000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $800000.0 in Q2 2021 to a low of -$8000.0 in Q2 2020.
  • Historically, Other financing activities has averaged $329666.7 across 3 years, with a median of $197000.0 in 2024.
  • Biggest YoY gain for Other financing activities was 10100.0% in 2021; the steepest drop was 10100.0% in 2021.
  • Year by year, Other financing activities stood at -$8000.0 in 2020, then skyrocketed by 10100.0% to $800000.0 in 2021, then crashed by 75.38% to $197000.0 in 2024.
  • Business Quant data shows Other financing activities for CRDF at $197000.0 in Q2 2024, $800000.0 in Q2 2021, and -$8000.0 in Q2 2020.